Is Sunshine Biopharma, Inc. (SBFM) Stock About to Get Hot Thursday?

Overall market sentiment has been high on Sunshine Biopharma, Inc. (SBFM) stock lately. SBFM receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sunshine Biopharma, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SBFM!

See Full SBFM Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SBFM Stock Today?

Sunshine Biopharma, Inc. (SBFM) stock is lower by -11.2% while the S&P 500 is up 0.31% as of 10:31 AM on Thursday, Sep 9. SBFM is lower by -$0.01 from the previous closing price of $0.13 on volume of 2,294,586 shares. Over the past year the S&P 500 is higher by 35.90% while SBFM is up 450.00%. SBFM lost -$0.03 per share in the over the last 12 months.

More About Sunshine Biopharma, Inc.

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Click Here to get the full Stock Report for Sunshine Biopharma, Inc. stock.